Science & Enterprise subscription

Follow us on Twitter

  • The Pew Research Center last month reported results of surveys about mobile phone use, conducted in 11 emerging eco… https://t.co/EEmV2FmKas
    about 14 hours ago
  • New post on Science and Enterprise: Infographic – Mobile Phones in Emerging Economies https://t.co/MXoyQkhwIu #Science #Business
    about 14 hours ago
  • Thank you @SciSeeker ... that's very kind. Where can I find a Science Seeker logo I can put on our site, to indicat… https://t.co/kXVMa32BHZ
    about 1 day ago
  • A biomedical engineering team devised techniques using a gel to produce more engineered T-cells, which in lab mice… https://t.co/d9GwEsAjxo
    about 2 days ago
  • New post on Science and Enterprise: Gel Boosts T-Cells for Cancer Treatments https://t.co/3SJaw4iYkL #Science #Business
    about 2 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Engineered Moth to Control Soybean Pest

Soybean looper caterpillar

A company providing genetically engineered insects to control threats to health and agriculture is designing a modified moth that now destroys soybeans and other crops. . . . → Read More: Engineered Moth to Control Soybean Pest

Biotechs Partner on Gene Silencing in $1.1B Deal

Retinal gene therapy

Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions. . . . → Read More: Biotechs Partner on Gene Silencing in $1.1B Deal

Biotechs Join Forces for Off-the-Shelf Stem Cells

Crispr genome edits illustration

Two biotechnology enterprises working in genome editing and regenerative medicine are sharing their technologies to develop off-the-shelf cell therapies. . . . → Read More: Biotechs Join Forces for Off-the-Shelf Stem Cells

Genetic Risk Analysis Shows Ethnic Bias

DNA puzzle

Techniques analyzing data from across the genome that reveal risks of diseases, better predict disorders in the main ethnicity of the population studied than other ethnic groups. . . . → Read More: Genetic Risk Analysis Shows Ethnic Bias

Genome Editing Biotech Raises $126M in IPO

NASDAQ share price display

A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock. . . . → Read More: Genome Editing Biotech Raises $126M in IPO

Start-Up Creating Off-the-Shelf Stem Cell Therapies

Chad Cowan

A new company is licensing technology from the lab of its co-founder at Harvard University to develop stem cell therapies for any recipients, without causing immune reactions. . . . → Read More: Start-Up Creating Off-the-Shelf Stem Cell Therapies

Ancient DNA Studied for Mental Health Clues

Eske Willerslev

A lab studying DNA from past civilizations and the genomics technology company Illumina are investigating remains of ancient peoples for insights into today’s neurological disorders. . . . → Read More: Ancient DNA Studied for Mental Health Clues

Crispr Diagnostics Company Launches with $35M Funding

Sherlock paper test strips

Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing. . . . → Read More: Crispr Diagnostics Company Launches with $35M Funding

Gates Supporting Infectious Antibody Discovery

Human B-cell

The Bill and Melinda Gates Foundation is enlisting a company that discovers therapeutic antibodies to help researchers develop new drugs and vaccines for serious infectious diseases. . . . → Read More: Gates Supporting Infectious Antibody Discovery

Microsoft, Biotech Partner on Gene, Cell Therapies

Computational biology illustration

A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies. . . . → Read More: Microsoft, Biotech Partner on Gene, Cell Therapies